Research Nester released a report titled “Psoriasis Drugs Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global psoriasis drugs market in terms of market segmentation by drug class, by route of administration, by distribution channel and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

The market for psoriasis drugs is projected to grow at a CAGR of about 9.8% over the forecast period, i.e., 2019-2027. The market is segmented by drug class, by route of administration, by distribution channel and by region, out of which, the drug class segment is further segmented into corticosteroids, tumor necrosis factor (TNF) alpha inhibitors, PDE4 inhibitors, interleukin inhibitors and others.

Get a PDF Sample for more detailed market insights:https://www.researchnester.com/sample-request-2144

The TNF alpha inhibitor segment holds the largest share in the psoriasis drugs market, however, the interleukin inhibitors segment is anticipated to witness the highest growth rate during the forecast period as a result of higher demand for these drugs over the conventional TNF alpha inhibitors.

Based on region, the market in North America is predicted to hold the largest share in the psoriasis drugs market on account of the growing prevalence of psoriasis in the region. Moreover, the growing number of government initiatives in favor of the psoriasis drugs along with the presence of developed healthcare infrastructure are some other factors predicted to result in growth of the market over the forecast period.

Rising prevalence of Psoriasis to Drive the Market Growth

According to a 2016 report World Health Organization, psoriasis can occur at any age, however, according to some studies, psoriasis begins to form at the age of 33 years. Other studies indicate that the disease occurs before the age of 46 years. Furthermore, the report indicated that the prevalence of psoriasis in various countries varies between 0.09% and 11.4%, while the prevalence in developed countries varies between 1.5% and 5%.

The rising incidences of psoriasis along with the growing awareness about the condition among people belonging to various countries is estimated to be a major driving factor for the market growth. However, the high cost of psoriasis drugs and the side-effects associated with it, including high blood pressure, liver damage and kidney damage, are estimated to hamper the market growth during this period.

This report also provides the existing competitive scenario of some of the key players of the global psoriasis drugs market which includes company profiling:

Pfizer Inc. PFE, +0.42%, Novartis AG (swx:NOVN), GlaxoSmithKline plc. (lon:GSK), Johnson & Johnson Services, Inc. JNJ, +0.16%, Amgen Inc. AMGN, +0.44%, Celgene Corporation, AbbVie Inc. ABBV, +0.14%, Eli Lilly and Company LLY, +0.34%, AstraZeneca (lon:AZN) and Biocon (nse:BIOCON).

Access Full Report, here: https://www.researchnester.com/sample-request-2144

The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global psoriasis drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

You need to be a member of Global Risk Community to add comments!

Join Global Risk Community

Votes: 0
Email me when people reply –

[Free COVID-19 Framework] What's the path to recovery look like?

We created a free presentation (attached), which discusses both global and organizational impacts of the COVID-19 pandemic, along with critical actions organizations should take immediately. This presentation introduces a framework that helps regions and organizations navigate a path to recovery via 9 potential scenarios. These scenarios capture outcomes related to GDP impact, public health response, and economic policies. The presentation also breaks down 6 immediate and critical actions…

Read more…
4 Replies · Reply by Steve Diaz Jul 8, 2023
Views: 205

If risk management is about decision making, are current risk management solutions irrelevant?

Now that the updated COSO and ISO risk management standards emphasize a connection to enterprise objectives and decision making, does this mean ERM and GRC solutions focused on risk registers and regulatory compliance are missing the true value of risk management?Will current risk management solutions evolve to integrate more decision support functionality or will standalone prescriptive analytics and other technology solutions take a more prominent role in enabling risk-informed…

Read more…
3 Replies
Views: 131

A question related to classification of instruments between trading and banking book.

We have an interesting question from one of our members.       "We usually perform OTC FX transactions with clients backed-to-back on the market (with Banks). Now we are going to perform a FX swap (i.e. Spot + forward) JPY/EUR for the Bank account for 1 week at the longest. The purpose is to get EUR place @ CB for LCR compliance purpose (no trading purposes). Bank's Management think that this should be considered as a trading position and therefore be classified within the Bank's trading book.…

Read more…
5 Replies · Reply by Prisha Singh Dec 26, 2023
Views: 311

Plunging oil prices: curse or blessing in disguise?

The recent sudden crash of oil prices has had a major impact on the world economy, leading to many troubled faces in the international arena. The Russians fear the effects of yet another powerful hit on their economy, Venezuela seems to be considering default and the Americans are weary of the consequences for its young and emerging shale oil industry. And then you have the Middle East, where the smallest match is enough to ignite the largest fire. But are these worries really justified or…

Read more…
1 Reply
Views: 90

Introducing the Global Risk Series - Book 1 Risk Management How Tos

Dear GlobalRisk Community member, Our community’s mission is to foster business, networking and educational explorations among members. Learn from some of the top experts in the industry as they clearly explain how to approach the most important Risk management concepts. Check out their expert tips and use the link at the end of each article to navigate back to the website to leave your comment or ask a question.   Some of the topics include: How do you Explain Risk Appetite?  How to Prepare a…

Read more…
16 Replies · Reply by GlobalRiskCommunity Mar 21
Views: 891

    About Us

    The GlobalRisk Community is a thriving community of risk managers and associated service providers. Our purpose is to foster business, networking and educational explorations among members. Our goal is to be the worlds premier Risk forum and contribute to better understanding of the complex world of risk.

    Business Partners

    For companies wanting to create a greater visibility for their products and services among their prospects in the Risk market: Send your business partnership request by filling in the form here!

lead